Your session is about to expire
← Back to Search
Teen Driving Intervention for Risky Teen Driving
N/A
Waitlist Available
Led By Jingzhen (Ginger) Yang, PhD, MPH
Research Sponsored by Ginger Yang
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to one year post-study period
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the STS program, which helps parents talk to their teens about safe driving. It targets teens who have committed traffic violations and uses a device to monitor driving habits. The goal is to improve teen driving safety by involving parents. Steering Teens Safe (STS) is a parent-focused program designed to improve parental communication with teens about safe driving using motivational interviewing techniques and safe driving lessons.
Who is the study for?
This trial is for teens aged 16-17 in Ohio who've been convicted of a moving violation and have a valid intermediate driver's license with car insurance. They must be the primary driver of a vehicle made after 1996, have access to a smartphone with Bluetooth, and not be enrolled in another driving study or unable to drive.
What is being tested?
The trial tests Steering Teens Safe (STS), an intervention that aims to improve teen driving safety by enhancing parent communication skills. It will compare two groups: one just gets device feedback on driving, while the other also receives virtual communication training for parents.
What are the potential side effects?
Since this is not a medical intervention, there are no traditional side effects. However, participants may experience increased stress or anxiety due to monitoring or changes in family dynamics from enhanced communication.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to one year post-study period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to one year post-study period
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Adoption of the intervention
Frequency of Parent-teen communications
Implementation fidelity
+3 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment2 Interventions
Parents will receive STS, which will include 1) Individualized virtual communication training and a booster session delivered by a traffic safety communication specialist; and 2) An online parent-teen safe driving communication guide. In addition, the Azūga™ in-vehicle device and app will be installed as described above and all feedback features will be enabled. Three types of feedback will be provided to teens: 1) Direct audio feedback; 2) Detailed cumulative driving data; and 3) A customized weekly driving summary report. Parents in this group will receive access to the teen's cumulative driving data and a weekly driving summary report. Additionally, a wireless mini-camera will be installed on the dashboard in teen's car to identify the participating driver using facial verification technology.
Group II: Control GroupActive Control1 Intervention
The Azūga™ in-vehicle driving feedback technology will be installed.32 This driving feedback technology consists of a pager-sized device plugged into the vehicle's on-board diagnostic (OBD) port (installed in the teen's car) and a smartphone app (downloaded on the teen's smartphone). All feedback features will be disabled. Control dyads will receive no driving feedback. The parent will not receive STS. Additionally, a wireless mini-camera will be installed on the dashboard in teen's car to identify the participating driver using facial verification technology.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Steering Teens Safe (STS)
2020
N/A
~180
Driving Feedback Technology.
2020
N/A
~180
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The Steering Teens Safe (STS) intervention aims to improve teen driving practices by enhancing parental communication skills. The mechanism of action involves providing parents with individualized virtual communication training and feedback on their teen's driving behavior.
This approach helps parents effectively communicate safe driving practices and reinforce positive behaviors. For driving patients, especially teens, this matters because improved parental guidance and communication can lead to reduced risky driving behaviors, fewer traffic violations, and overall safer driving outcomes.
Feasibility of DriveFocus™ and Driving Simulation Interventions in Young Drivers.
Feasibility of DriveFocus™ and Driving Simulation Interventions in Young Drivers.
Find a Location
Who is running the clinical trial?
Ginger YangLead Sponsor
2 Previous Clinical Trials
1,060 Total Patients Enrolled
University of IowaOTHER
470 Previous Clinical Trials
894,600 Total Patients Enrolled
Jingzhen (Ginger) Yang, PhD, MPHPrincipal InvestigatorNationwide Children's Hospital
2 Previous Clinical Trials
1,060 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:Research Study Groups:
This trial has the following groups:- Group 1: Control Group
- Group 2: Intervention Group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.